Cargando…
Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
This report shows poor adherence to the recommended treatment regimen for NTM-PD patients, which may pose a potential risk for the development of macrolide resistance. The risk was highest among elderly patients, and those with rheumatoid arthritis and COPD. http://bit.ly/3aBoUzE
Autores principales: | Izumi, Kiyohiko, Morimoto, Kozo, Uchimura, Kazuhiro, Ato, Manabu, Hasegawa, Naoki, Mitarai, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086070/ https://www.ncbi.nlm.nih.gov/pubmed/32211437 http://dx.doi.org/10.1183/23120541.00097-2019 |
Ejemplares similares
-
Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan
por: Namkoong, Ho, et al.
Publicado: (2016) -
Diagnostic Utility of a Mycobacterium Multiplex PCR Detection Panel for Tuberculosis and Nontuberculous Mycobacterial Infections
por: Uwamino, Yoshifumi, et al.
Publicado: (2023) -
Evaluation of “international transfer-out” among foreign-born pulmonary tuberculosis patients in Japan – what are the implications for a cross-border patient referral system?
por: Kawatsu, Lisa, et al.
Publicado: (2018) -
Treatment outcome of multidrug-resistant tuberculosis in Japan – the first cross-sectional study of Japan tuberculosis surveillance data
por: Kawatsu, Lisa, et al.
Publicado: (2018) -
Anti-Mycobacterial Drug Resistance in Japan: How to Approach This Problem?
por: Kamada, Keisuke, et al.
Publicado: (2021)